The settlement agreement proposes to resolve 8,000 claims filed by patients who received Johnson & Johnson's defective DePuy Articular Surface Replacement (ASR)
Hip System devices.
Not exact matches
A California jury ruled on March 8, 2013 that DePuy Orthopaedics knowingly produced and marketed a defective
hip replacement device known as the DePuy ASR ™ Hip Resurfacing Syst
hip replacement
device known as the DePuy ASR ™
Hip Resurfacing Syst
Hip Resurfacing
System.
While these two
hip implant
systems are not considered metal - on - metal
hip devices (although they do have a metal - on - metal junction because their necks are made of cobalt and chromium and the stems are coated in titanium), they do pose similar complications.
For others, however,
hip replacement
devices result in pain, additional surgeries and diffusion of metal ions in the bloodstream, causing a variety of problems in the heart, nervous
system and thyroid gland.
One of these
devices, the Stryker Rejuvenate
hip replacement
system, is causing many patients post-implant complications.
While
hip replacement
devices are generally associated with older people, the Stryker Rejuvenate
system was marketed with younger patients in mind.
Such medical
devices include Wright Medical Technology's Conserve
Hip Implant
System, Stryker Orthopedic's Rejuvenate, ABG II, and Accolade models, and DePuy's ASR models.
Defective medical
devices have caused major problems: DePuy's ASR Acetublar
hip replacement
system was not recalled until almost two years after issues arose.